首页> 美国政府科技报告 >Studies for the Prevention and Treatment of Malaria, Leishmania, and Other Emerging Infectious Diseases in Brazil
【24h】

Studies for the Prevention and Treatment of Malaria, Leishmania, and Other Emerging Infectious Diseases in Brazil

机译:巴西疟疾,利什曼原虫和其他新发传染病的预防和治疗研究

获取原文

摘要

Visceral leishmaniasis is an infection of the reticuloendothelial system caused by a protozoan of the Leishmania donovani complex. The lack of orally effective agents for visceral leishmaniasis prompted the clinical development of WR6026, a primaquine analog found to be highly active in animal testing. This study was an open-label, dose-escalating trial of WR6026 in the treatment of visceral leishmaniasis caused by L. chagasi.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号